Serum Endostatin Is a Novel Marker for COPD Associated with Lower Lung Function, Exacerbation and Systemic Inflammation
Yanqiu Wu,1,2 Jiangyue Qin,1,2 Junyun He,3 Yongchun Shen,1,2 Hao Wang,1,2 Yanping Li,4 Qianglin Zeng,5 Jiajia Dong,1,2 Yunfei An,6 Shuguang Xiong,7 Mei Feng,2 Fuqiang Wen1,2 1Division of Pulmonary Diseases, State Key Laboratory of Biotherapy of China, West China Hospital of Sichuan University, Cheng...
Main Authors: | Wu Y, Qin J, He J, Shen Y, Wang H, Li Y, Zeng Q, Dong J, An Y, Xiong S, Feng M, Wen F |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-02-01
|
Series: | International Journal of COPD |
Subjects: | |
Online Access: | https://www.dovepress.com/serum-endostatin-is-a-novel-marker-for-copd-associated-with-lower-lung-peer-reviewed-article-COPD |
Similar Items
-
Endostatin and Cancer Therapy: A Novel Potential Alternative to Anti-VEGF Monoclonal Antibodies
by: Gabriel Méndez-Valdés, et al.
Published: (2023-02-01) -
Endostatin in Renal and Cardiovascular Diseases
by: Mei Li, et al.
Published: (2021-09-01) -
Comparisons of biophysical properties and bioactivities of mono-PEGylated endostatin and an endostatin analog
by: Shan Wang, et al.
Published: (2016-01-01) -
The Challenges of Recombinant Endostatin in Clinical Application: Focus on the Different Expression Systems and Molecular Bioengineering
by: Abbas Mohajeri, et al.
Published: (2017-04-01) -
Serum Endostatin Levels in Oral Squamous Cell Carcinoma
by: Maryam Mardani, et al.
Published: (2018-05-01)